HerbsForever- Hingwastika Churna ; Ayruvedic Herbal Supplement; 90 VEGE Capsules; 100 GMS UPC: 8 07814 00622 4
HerbsForever- Hingwastika Churna ; Ayruvedic Herbal Supplement; 90 VEGE Capsules; 100 GMS UPC: 8 07814 00622 4 was recalled because potential undeclared allergen ingredient (wheat). If you have this product, stop using it until you verify your lot or model details.
By RecallRadar Editorial Team
Sourced from FDA. Last verified April 15, 2026.
On this page
Free checker
Check if you qualify
See whether your device may qualify for a free repair or replacement program before you spend money.
Check if you qualifyKey facts
- Date announced
- January 21, 2026
- Source agency
- FDA
This recall involves safety concerns. Take action promptly.
✨ Plain-English Summary
HerbsForever- Hingwastika Churna ; Ayruvedic Herbal Supplement; 90 VEGE Capsules; 100 GMS UPC: 8 07814 00622 4 was recalled because potential undeclared allergen ingredient (wheat). If you have this product, stop using it until you verify your lot or model details.
Is This Recall Still Active?
Status: Yes - Active
This recall is currently active. If your device matches the affected models, follow the official instructions as soon as possible.
What's Being Recalled
Quoted source excerpt from the official notice.
Potential undeclared allergen ingredient (Wheat)
Quick Info
Key facts from the official notice, kept in the article flow for easy cross-checking.
- Brand
- Herbs forever
- Category
- food
- Source agency
- FDA
- Announced
- January 21, 2026
- Country
- US
- Status
- Active
Who's Affected
Specific models and identifiers listed in the source notice:
Model #1
Batch: 622-2 Expiration date: 6/2029
| # | Model |
|---|---|
| 1 | Batch: 622-2 Expiration date: 6/2029 |
Technical model codes are manufacturer identifiers. Match both the product name and model code from your device settings, label, or packaging.
What You Should Do
Follow the remedy path from the official notice using the exact model and serial details above.
- 1Stop using the affected product until you verify whether your item is impacted.
- 2Check the official recall notice and match your model, lot, or serial details.
- 3Follow the official instructions for repair, replacement, refund, or disposal.
Source & Verification
This page summarizes the official notice and keeps key facts easy to verify.
- Official source
- FDA
- Announced by source
- January 21, 2026
- Last reviewed by RecallRadar
- April 15, 2026
Frequently Asked Questions
Am I affected by this recall?
Check the affected models section on this page. The official notice currently lists Batch: 622-2 Expiration date: 6/2029.
What is the remedy for this recall?
Follow the official instructions for repair, replacement, refund, or disposal on the herbs forever recall page.
Where can I verify recall details?
Use the official source link in this page to confirm dates, eligibility, and next steps: https://api.fda.gov/food/enforcement.json?search=recall_number:H-0405-2026&limit=1
Keep browsing with these internal hubs: herbs forever recall hub and Food & Drug recall hub.
Official Resources
Use these primary sources for final eligibility and claim instructions.
View official notice from FDASee an inaccuracy?
Help us improve the accuracy of this recall information.
On this page
Free checker
Check if you qualify
See whether your device may qualify for a free repair or replacement program before you spend money.
Check if you qualifyKey facts
- Date announced
- January 21, 2026
- Source agency
- FDA
Related Recalls
Liraglutide Injection, 18 mg/3 mL (6 mg/mL), Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Naples, FL 34108, Manufactured by: Lupin Limited, Nagpur 441108, INDIA, a) 2 Pens- NDC 70748-346-02; b) 3 Pens - NDC 70748-346-03.
Presence of particulate matter: a white thread-like structure in the cartridge
May 27, 2026
Erythromycin Tablets, USP, 500 mg, 30 tablets per bottle, Rx only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534; (NDC 70710-1048-3).
CGMP Deviations; presence of N-Nitroso-Desmethyl-Erythromycin above the recommended acceptable intake limit
May 27, 2026
fentaNYL Citrate, Sterile CADD for Injection, 2,2500 mcg/50mL in Sterile Water, IntegraDose Compounding Services LLC, 3650 Victorie St N, Suite 900, Shoreview, MN, NDC 71139-6030-1.
Subpotent Drug
May 27, 2026
Atomoxetine Capsules HCL, 10 mg Capsules in unit dose foil strip, strips are packed in cartons of 100, Rx Only, Pkg by: Safecor, Columbus, OH 43204. NDC: 64380-474-01
Labeling: Label Mix-Up: Atomoxetine HCl 25mg Capsule incorrectly labeled as Atomoxetine HCl 10mg Capsule.
May 27, 2026
Primidone Tablets, USP, 50 mg, 50-count bottle, RX only, Manufactured by: Lannett Company, Inc., Marketed by: GSMS, Incorporated, Camarillo, CA 93012. NDC 51407-637-05
Cross contamination with other products: API contaminated with trace amounts of Acemetacin API.
May 27, 2026